AngioDynamics Inc. (NASDAQ: ANGO) reported a net loss for the second quarter of 2025 as the medical device company’s revenues decreased 8%.
AngioDynamics (ANGO) reports net loss for Q2 2025; sales drop 8%
Categories
medical device
Intuitive Surgical stock dips after mixed Q3 earnings. What’s in store?
Intuitive Surgical, Inc. (NASDAQ: ISRG) produces and sells some of the most advanced robotic surgical systems that make medical procedures simpler and
Why AngioDynamics (ANGO) deserves a place on investors’ watchlist
The market reopening has created a conducive atmosphere to carry out elective medical procedures which were deferred on a large scale during